Dr. Tessa van der Geest
As part of our series of interviews with the PedCRIN Consortium members, we had the pleasure to speak with Tessa van der Geest to ask about the role of Radboud University Medical Center (RUMC, The Netherlands) in the PedCRIN project.
RUMC co-leads PedCRIN WP4 (Pilot Trials) along with ECRIN and HUS-FI. The main task of this WP is to provide support for the PedCRIN funded pilot trials and to cover services as transnational access for the countries outside the sponsor country. These services only include regulatory and ethical submissions, trial monitoring, pharmacovigilance, support for insurance, trial product and biosample management. And does not provide any support or services for the clinical investigation neither at site level (study nurses, local logistics) nor through disease-specific investigation networks.
RUMC is responsible for the launch of the call, selection of the projects, and the formation of the scientific advisory board and is contributing to the reports that are and will be written during the project.